High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries
High total serum cholesterol, medication coverage and therapeutic control: an analysis of national health examination survey data from eight countries
复制标题
DOI：
10.2471/blt.10.079947
复制
发表时间：
2011-02-01
期刊：
影响因子：
--
通讯作者：
Lim, Stephen S
中科院分区：
文献类型：
--
作者：
Roth, Gregory A;Fihn, Stephan D;Lim, Stephen S
目的确定在8个高收入和中等收入国家中，血清总胆固醇高的个体得到诊断和有效治疗的比例。方法使用1998-2007年进行的全国代表性健康检查调查的数据，我们研究了来自英格兰、德国、日本、约旦、墨西哥、苏格兰、泰国和美利坚合众国。对于每个国家，我们计算了高血清总胆固醇（血清总胆固醇>= 6.2 mmol/l或>= 240 mg/dl）的患病率和平均血清总胆固醇水平。我们还确定了被诊断、接受降胆固醇药物治疗和有效控制的个体的分数（血清总胆固醇
Objective To determine the fraction of individuals with high total serum cholesterol who get diagnosed and effectively treated in eight high- and middle-income countries.Methods Using data from nationally representative health examination surveys conducted in 1998-2007, we studied a probability sample of 79039 adults aged 40-79 years from England, Germany, Japan, Jordan, Mexico, Scotland, Thailand and the United States of America. For each country we calculated the prevalence of high total serum cholesterol (total serum cholesterol >= 6.2 mmol/l or >= 240 mg/dl) and the mean total serum cholesterol level. We also determined the fractions of individuals being diagnosed, treated with cholesterol-lowering medication and effectively controlled (total serum cholesterol